Release date: 2025-02-18 14:17:28 Article From: Lucius Laos Recommended: 108
Cabozantinib is a multi-kinase inhibitor with a wide range of clinical applications. This article will discuss the dosage of cabozantinib and its associated factors, as well as the precautions when using it.
The dosage of cabozantinib should be determined based on the patient's specific situation and the doctor's recommendation.
The recommended starting dose of cabozantinib is usually 60 mg once daily. This is based on the results of multiple clinical trials that balance efficacy and safety.
In practice, the physician may adjust the dose based on the patient's tolerance, disease progression, and adverse effects. For example, if a patient experiences serious adverse effects, the dose may need to be reduced; If disease progression is slow and well tolerated, an increase in dose may be considered.
For patients with hepatic and renal insufficiency, as well as the elderly and children, the dosage of cabozantinib may need to be specially adjusted. These patients should be closely monitored for response to cabozantinib and dose adjusted under the guidance of a physician.
There are some key considerations that patients need to understand and follow when using cabozantinib.
During the use of cabozantinib, patients should regularly monitor blood routine, liver and kidney function and other indicators. These tests can help identify and manage potential adverse effects in a timely manner.
Cabozantinib can interact with a variety of medications, affecting efficacy or increasing side effects. Therefore, patients should inform their doctor of all medications they are taking, including prescription and over-the-counter medications, and supplements, before using cabozantinib.
During the use of cabozantinib, patients should pay attention to maintaining good lifestyle habits, such as reasonable diet, moderate exercise, and adequate sleep. These measures help to strengthen the body's resistance and reduce the side effects of medications.
The dosage of cabozantinib should be determined based on the patient's specific situation and physician's recommendations, and patients should be aware of and follow some key precautions during use, such as regular monitoring, attention to drug interactions, and lifestyle modifications. Through scientific and rational medication and lifestyle adjustment, patients can better exert the efficacy of cabozantinib and improve their quality of life
Lung cancer is the most rapidly increasing malignant tumor with the fastest increasing morbidity and···【more】
Recommended:2012024-09-07
On November 14, 2024, the Committee for Medicinal Products for Human Use (CHMP) of the European Medi···【more】
Recommended:1582025-13-01
Recent advancements have reaffirmed the significance of liquid biopsy in the management of advanced ···【more】
Recommended:1562025-06-01
FDA Approves First Generic Version of Victoza (liraglutide injection)The U.S. Food and Drug Administ···【more】
Recommended:1712024-30-12
The new indication involves the treatment of adult patients with locally advanced, unresectable non-···【more】
Recommended:1612024-24-12
he U.S. Food and Drug Administration (FDA) has approved Crenessity (crinecerfont) for use in combina···【more】
Recommended:1462024-17-12
In the phase Ib/II multicenter pivotal FELIX study, the autologous 41BB-ζ anti-CD19 chimeric antigen···【more】
Recommended:1052024-13-12
On 25 July 2024, the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHM···【more】
Recommended:2482024-26-08
Lucius Pharmaceutical Co., Ltd., was established in 2020 in Vientiane, the capital of Laos. It aims to offer safe, effective, and affordable medicines globally. With a factory spanning 25,000 square meters, the company manufactures 200+ generic drugs in diverse therapeutic fields.
Address:No.26 Thongmang village, Xaythany district, Vientiane Capital, Laos
E-mail:laoslucius@gmail.com
Whatsapp: